Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
CVS Group plc ( (GB:CVSG) ) has provided an update.
CVS Group plc has published a prospectus ahead of moving its existing ordinary shares from AIM to the Main Market of the London Stock Exchange on 29 January 2026, without raising new capital, a step that is expected to enhance its market profile while maintaining its current ticker and ISIN. In an accompanying trading update for the six months to 31 December 2025, the company reported 5.8% revenue growth to £356.9m and a 3.9% rise in adjusted EBITDA to £67.7m, alongside ongoing investment in technology and practice infrastructure, the rollout of its new ‘CVS Vets’ dual branding in UK companion animal sites, and continued expansion in Australia, where it now operates 32 practices across 54 sites. Employee engagement showed improvement, leverage rose in line with expectations to 1.41x following capital expenditure, acquisitions and a share buyback, and the group said performance remains on track with full-year expectations despite UK consumer headwinds, while it continues to engage with the Competition and Markets Authority on proposed remedies arising from the sector-wide market investigation.
The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1465.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.
Spark’s Take on GB:CVSG Stock
According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.
CVS Group plc’s overall stock score is driven by strong financial performance and positive earnings call highlights, including revenue growth and successful acquisitions. However, the high P/E ratio and low dividend yield suggest overvaluation, while technical indicators point to potential overbought conditions. Challenges in the UK market and past cyber incidents also weigh on the score.
To see Spark’s full report on GB:CVSG stock, click here.
More about CVS Group plc
CVS Group plc is a leading provider of veterinary services operating in the UK and Australia, focused on delivering high-quality clinical care to companion animals through around 470 practices, including specialist referral hospitals and out-of-hours sites. Alongside its core veterinary practices division, the group runs diagnostic laboratories serving both internal and third-party clients, as well as an online retail business, and employs about 8,900 staff, including roughly 2,500 veterinary surgeons and 3,300 nurses and patient care assistants.
Average Trading Volume: 593,129
Technical Sentiment Signal: Buy
Current Market Cap: £935.8M
For a thorough assessment of CVSG stock, go to TipRanks’ Stock Analysis page.